H2BC1
gene geneOn this page
Also known as bA317E16.3STBPTSH2BH2BFU
Summary
H2BC1 (H2B clustered histone 1, HGNC:18730) is a protein-coding gene on chromosome 6p22.2, encoding Histone H2B type 1-A (Q96A08). Variant histone specifically required to direct the transformation of dissociating nucleosomes to protamine in male germ cells.
Histones are basic nuclear proteins that are responsible for the nucleosome structure of the chromosomal fiber in eukaryotes. Nucleosomes consist of approximately 146 bp of DNA wrapped around a histone octamer composed of pairs of each of the four core histones (H2A, H2B, H3, and H4). The chromatin fiber is further compacted through the interaction of a linker histone, H1, with the DNA between the nucleosomes to form higher order chromatin structures. This gene is intronless and encodes a replication-dependent histone that is a testis/sperm-specific member of the histone H2B family. Transcripts from this gene contain a palindromic termination element.
Source: NCBI Gene 255626 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 37 total
- Druggable target: yes
- MANE Select transcript:
NM_170610
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18730 |
| Approved symbol | H2BC1 |
| Name | H2B clustered histone 1 |
| Location | 6p22.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | bA317E16.3, STBP, TSH2B, H2BFU |
| Ensembl gene | ENSG00000146047 |
| Ensembl biotype | protein_coding |
| OMIM | 609904 |
| Entrez | 255626 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000274764
RefSeq mRNA: 1 — MANE Select: NM_170610
NM_170610
CCDS: CCDS4563
Canonical transcript exons
ENST00000274764 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000973630 | 25726777 | 25727345 |
Expression profiles
Bgee: expression breadth broad, 23 present calls, max score 94.24.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 23.8535 / max 17303.1689, expressed in 165 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 66444 | 23.8535 | 165 |
Top tissues by expression
240 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 94.24 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 86.35 | gold quality |
| left testis | UBERON:0004533 | 69.00 | gold quality |
| right testis | UBERON:0004534 | 68.29 | gold quality |
| testis | UBERON:0000473 | 67.98 | gold quality |
| pancreatic ductal cell | CL:0002079 | 56.30 | silver quality |
| sperm | CL:0000019 | 54.93 | silver quality |
| cardiac muscle of right atrium | UBERON:0003379 | 54.34 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 54.23 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 54.20 | gold quality |
| kidney epithelium | UBERON:0004819 | 53.93 | gold quality |
| tibialis anterior | UBERON:0001385 | 53.83 | silver quality |
| upper arm skin | UBERON:0004263 | 53.52 | gold quality |
| myocardium | UBERON:0002349 | 50.25 | gold quality |
| lower lobe of lung | UBERON:0008949 | 50.08 | silver quality |
| ileal mucosa | UBERON:0000331 | 48.75 | silver quality |
| deltoid | UBERON:0001476 | 48.67 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 47.03 | gold quality |
| quadriceps femoris | UBERON:0001377 | 46.74 | gold quality |
| vastus lateralis | UBERON:0001379 | 45.40 | gold quality |
| layer of synovial tissue | UBERON:0007616 | 43.55 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| secondary oocyte | CL:0000655 | 42.57 | gold quality |
| colonic epithelium | UBERON:0000397 | 41.42 | gold quality |
| superficial temporal artery | UBERON:0001614 | 41.33 | gold quality |
| muscle tissue | UBERON:0002385 | 41.17 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 41.10 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 41.05 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 40.98 | gold quality |
| cartilage tissue | UBERON:0002418 | 40.77 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.99 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 4)
- Reconstituted TSH2B containing octamers are able to form nucleosome core particles which are structurally and dynamically indistinguishable from those reconstituted with octamers consisting of only native histones. (PMID:15709765)
- Data show that histone H2B of prostate cancer cell line DU-145 have hypoacetylation, hypomethylation, and dephosphorylation, suggesting there was an excessive histone deacetylase activity in the cells. (PMID:26759222)
- In a process of single-strand DNA repair, PARP3 mono-ADP-ribosylates nucleosomal histone H2B. (PMID:27716488)
- Data indicate that lactate dehydrogenase A (LDHA) is involved in the transcription of histone 2B gene. (PMID:28257841)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | H2bc1 | ENSMUSG00000050799 |
| rattus_norvegicus | H2bc1 | ENSRNOG00000084925 |
Paralogs (21): H2BW2 (ENSG00000101812), H2BW1 (ENSG00000123569), H2BC11 (ENSG00000124635), H2BC5 (ENSG00000158373), H2BC4 (ENSG00000180596), H2BC21 (ENSG00000184678), H2BC13 (ENSG00000185130), H2BC26 (ENSG00000196890), H2BC12 (ENSG00000197903), H2BC18 (ENSG00000203814), H2BC15 (ENSG00000233822), H2BC12L (ENSG00000234289), H2BC14 (ENSG00000273703), H2BC8 (ENSG00000273802), H2BC6 (ENSG00000274290), H2BC17 (ENSG00000274641), H2BC9 (ENSG00000275713), H2BC3 (ENSG00000276410), H2BC7 (ENSG00000277224), H2BC10 (ENSG00000278588), H2BK1 (ENSG00000285480)
Protein
Protein identifiers
Histone H2B type 1-A — Q96A08 (reviewed: Q96A08)
Alternative names: Histone H2B, testis, Testis-specific histone H2B
All UniProt accessions (1): Q96A08
UniProt curated annotations — full annotation on UniProt →
Function. Variant histone specifically required to direct the transformation of dissociating nucleosomes to protamine in male germ cells. Entirely replaces classical histone H2B prior nucleosome to protamine transition and probably acts as a nucleosome dissociating factor that creates a more dynamic chromatin, facilitating the large-scale exchange of histones. Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling. Also found in fat cells, its function and the presence of post-translational modifications specific to such cells are still unclear.
Subunit / interactions. The nucleosome is a histone octamer containing two molecules each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and two H2A-H2B heterodimers.
Subcellular location. Nucleus. Chromosome.
Tissue specificity. Mainly expressed in testis, and the corresponding protein is also present in mature sperm (at protein level). Also found in some fat cells.
Post-translational modifications. Monoubiquitination at Lys-36 (H2BK34Ub) by the MSL1/MSL2 dimer is required for histone H3 ‘Lys-4’ (H3K4me) and ‘Lys-79’ (H3K79me) methylation and transcription activation at specific gene loci, such as HOXA9 and MEIS1 loci. Similarly, monoubiquitination at Lys-122 (H2BK120Ub) by the RNF20/40 complex gives a specific tag for epigenetic transcriptional activation and is also prerequisite for histone H3 ‘Lys-4’ and ‘Lys-79’ methylation. It also functions cooperatively with the FACT dimer to stimulate elongation by RNA polymerase II. H2BK120Ub also acts as a regulator of mRNA splicing: deubiquitination by USP49 is required for efficient cotranscriptional splicing of a large set of exons. Crotonylation (Kcr) is specifically present in male germ cells and marks testis-specific genes in post-meiotic cells, including X-linked genes that escape sex chromosome inactivation in haploid cells. Crotonylation marks active promoters and enhancers and confers resistance to transcriptional repressors. It is also associated with post-meiotically activated genes on autosomes. Acetylated during spermatogenesis. Acetylated form is most abundant in spermatogonia compared to spermatocytes and round spermatids. Phosphorylated at Thr-117 in spermatogonia, spermatocytes and round spermatids. Methylated at Lys-118 in spermatogonia, spermatocytes and round spermatids. Lactylated in macrophages by EP300/P300 by using lactoyl-CoA directly derived from endogenous or exogenous lactate, leading to stimulates gene transcription.
Similarity. Belongs to the histone H2B family.
RefSeq proteins (1): NP_733759* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000558 | Histone_H2B | Family |
| IPR007125 | H2A/H2B/H3 | Domain |
| IPR009072 | Histone-fold | Homologous_superfamily |
| IPR055333 | HISTONE_H2B_site | Conserved_site |
Pfam: PF00125
UniProt features (72 total): modified residue 57, cross-link 4, helix 4, sequence conflict 3, initiator methionine 1, chain 1, region of interest 1, strand 1
Structure
Experimental structures (PDB)
5 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 6BIY | X-RAY DIFFRACTION | 2.05 |
| 8VLR | ELECTRON MICROSCOPY | 2.6 |
| 3WKJ | X-RAY DIFFRACTION | 2.8 |
| 5GT3 | X-RAY DIFFRACTION | 2.91 |
| 5GSU | X-RAY DIFFRACTION | 3.1 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96A08-F1 | 84.88 | 0.70 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (61): 13, 13, 13, 13, 14, 14, 17, 17, 17, 17, 18, 18, 18, 18, 18, 22, 22, 22, 22, 22 …
Function
Pathways and Gene Ontology
Reactome pathways
58 pathways
| ID | Pathway |
|---|---|
| R-HSA-110328 | Recognition and association of DNA glycosylase with site containing an affected pyrimidine |
| R-HSA-110329 | Cleavage of the damaged pyrimidine |
| R-HSA-110330 | Recognition and association of DNA glycosylase with site containing an affected purine |
| R-HSA-110331 | Cleavage of the damaged purine |
| R-HSA-1221632 | Meiotic synapsis |
| R-HSA-171306 | Packaging Of Telomere Ends |
| R-HSA-1912408 | Pre-NOTCH Transcription and Translation |
| R-HSA-201722 | Formation of the beta-catenin:TCF transactivating complex |
| R-HSA-212300 | PRC2 methylates histones and DNA |
| R-HSA-2299718 | Condensation of Prophase Chromosomes |
| R-HSA-2559580 | Oxidative Stress Induced Senescence |
| R-HSA-2559582 | Senescence-Associated Secretory Phenotype (SASP) |
| R-HSA-2559586 | DNA Damage/Telomere Stress Induced Senescence |
| R-HSA-3214815 | HDACs deacetylate histones |
| R-HSA-3214847 | HATs acetylate histones |
| R-HSA-427359 | SIRT1 negatively regulates rRNA expression |
| R-HSA-427389 | ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression |
| R-HSA-427413 | NoRC negatively regulates rRNA expression |
| R-HSA-5250924 | B-WICH complex positively regulates rRNA expression |
| R-HSA-5334118 | DNA methylation |
| R-HSA-5578749 | Transcriptional regulation by small RNAs |
| R-HSA-5617472 | Activation of anterior HOX genes in hindbrain development during early embryogenesis |
| R-HSA-5625886 | Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 |
| R-HSA-5689880 | Ub-specific processing proteases |
| R-HSA-5693565 | Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks |
| R-HSA-5693571 | Nonhomologous End-Joining (NHEJ) |
| R-HSA-5693607 | Processing of DNA double-strand break ends |
| R-HSA-606279 | Deposition of new CENPA-containing nucleosomes at the centromere |
| R-HSA-68616 | Assembly of the ORC complex at the origin of replication |
| R-HSA-69473 | G2/M DNA damage checkpoint |
MSigDB gene sets: 187 (showing top):
GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_MCMV_INFECTION_DN, REACTOME_MEIOTIC_RECOMBINATION, GOBP_CHROMOSOME_ORGANIZATION, REACTOME_DNA_REPLICATION, REACTOME_SIGNALING_BY_NOTCH, REACTOME_ADAPTIVE_IMMUNE_SYSTEM, REACTOME_MEIOTIC_SYNAPSIS, GOBP_INFLAMMATORY_RESPONSE, REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT, GOCC_CELL_SURFACE, MEF2_02, GOBP_MALE_GAMETE_GENERATION, REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS, GOBP_LEUKOCYTE_MIGRATION, GOBP_PROTEIN_MATURATION
GO Biological Process (8): nucleosome assembly (GO:0006334), nucleosome disassembly (GO:0006337), inflammatory response (GO:0006954), plasminogen activation (GO:0031639), sperm DNA condensation (GO:0035092), chromosome organization (GO:0051276), mononuclear cell migration (GO:0071674), chromatin organization (GO:0006325)
GO Molecular Function (4): DNA binding (GO:0003677), structural constituent of chromatin (GO:0030527), histone binding (GO:0042393), protein heterodimerization activity (GO:0046982)
GO Cellular Component (7): chromosome, telomeric region (GO:0000781), nucleosome (GO:0000786), female germ cell nucleus (GO:0001674), nucleus (GO:0005634), nucleoplasm (GO:0005654), cell surface (GO:0009986), chromosome (GO:0005694)
Reactome top-level categories
Rollup of top-12 pathways:
| Category | Pathways |
|---|---|
| Cellular Senescence | 3 |
| Depyrimidination | 2 |
| Depurination | 2 |
| Epigenetic regulation of gene expression | 2 |
| Chromatin modifying enzymes | 2 |
| Negative epigenetic regulation of rRNA expression | 2 |
| Positive epigenetic regulation of rRNA expression | 2 |
| Meiosis | 1 |
| Telomere Maintenance | 1 |
| Pre-NOTCH Expression and Processing | 1 |
| TCF dependent signaling in response to WNT | 1 |
| Mitotic Prophase | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| chromatin organization | 2 |
| nucleosome organization | 2 |
| chromatin | 2 |
| cellular anatomical structure | 2 |
| protein-DNA complex assembly | 1 |
| protein-DNA complex disassembly | 1 |
| defense response | 1 |
| zymogen activation | 1 |
| spermatid nucleus differentiation | 1 |
| organelle organization | 1 |
| leukocyte migration | 1 |
| cellular component organization | 1 |
| nucleic acid binding | 1 |
| structural molecule activity | 1 |
| protein binding | 1 |
| protein dimerization activity | 1 |
| chromosomal region | 1 |
| protein-DNA complex | 1 |
| germ cell nucleus | 1 |
| intracellular membrane-bounded organelle | 1 |
| nuclear lumen | 1 |
| intracellular membraneless organelle | 1 |
Protein interactions and networks
STRING
2364 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| H2BC1 | PLG | P00747 | 867 |
| H2BC1 | RNF20 | Q5VTR2 | 833 |
| H2BC1 | H3C1 | P02295 | 825 |
| H2BC1 | H3-4 | Q16695 | 817 |
| H2BC1 | H3-5 | Q6NXT2 | 816 |
| H2BC1 | H3-3A | P06351 | 815 |
| H2BC1 | H3C14 | Q71DI3 | 815 |
| H2BC1 | H3-7 | Q5TEC6 | 813 |
| H2BC1 | RNF40 | O75150 | 772 |
| H2BC1 | H2AC19 | P20670 | 772 |
| H2BC1 | H2AC20 | Q16777 | 772 |
| H2BC1 | H2AC1 | Q96QV6 | 767 |
| H2BC1 | H4C7 | Q99525 | 751 |
| H2BC1 | H4C16 | P02304 | 747 |
| H2BC1 | DET1 | Q7L5Y6 | 730 |
IntAct
36 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| H2BC1 | PPM1G | psi-mi:“MI:0914”(association) | 0.640 |
| SFMBT1 | H4C16 | psi-mi:“MI:0914”(association) | 0.460 |
| H2BC1 | H2BC21 | psi-mi:“MI:0915”(physical association) | 0.400 |
| H4C16 | psi-mi:“MI:0915”(physical association) | 0.400 | |
| H2AC7 | psi-mi:“MI:0915”(physical association) | 0.400 | |
| H2BC1 | BRD7 | psi-mi:“MI:0915”(physical association) | 0.400 |
| CREB1 | NFIX | psi-mi:“MI:0914”(association) | 0.350 |
| MEF2A | REV3L | psi-mi:“MI:0914”(association) | 0.350 |
| NFATC1 | SMARCA5 | psi-mi:“MI:0914”(association) | 0.350 |
| NFKB1 | NFKB1 | psi-mi:“MI:0914”(association) | 0.350 |
| JUN | psi-mi:“MI:0914”(association) | 0.350 | |
| JUN | TPM3 | psi-mi:“MI:0914”(association) | 0.350 |
| COX15 | SNRPGP15 | psi-mi:“MI:0914”(association) | 0.350 |
| PDHA1 | psi-mi:“MI:0914”(association) | 0.350 | |
| COX15 | MYO1C | psi-mi:“MI:0914”(association) | 0.350 |
| COX15 | SAP18 | psi-mi:“MI:0914”(association) | 0.350 |
| RMND5A | HTRA2 | psi-mi:“MI:0914”(association) | 0.350 |
| CRY1 | IGKV2D-30 | psi-mi:“MI:0914”(association) | 0.350 |
| ELK4 | MYO1C | psi-mi:“MI:0914”(association) | 0.350 |
| P | psi-mi:“MI:0914”(association) | 0.350 | |
| CBX8 | IGF2BP3 | psi-mi:“MI:0914”(association) | 0.350 |
| HNRNPDL | psi-mi:“MI:0914”(association) | 0.350 | |
| POLR3A | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (483): HIST1H2BA (Affinity Capture-MS), HDAC1 (Reconstituted Complex), HDAC2 (Reconstituted Complex), HDAC3 (Reconstituted Complex), NAP1L1 (Affinity Capture-MS), RUVBL1 (Affinity Capture-MS), MIER1 (Affinity Capture-MS), HDAC1 (Affinity Capture-MS), EP400 (Affinity Capture-MS), GON4L (Affinity Capture-MS), MEAF6 (Affinity Capture-MS), H2AFY2 (Affinity Capture-MS), H2AFY (Affinity Capture-MS), SUPT16H (Affinity Capture-MS), LIG3 (Affinity Capture-MS)
ESM2 similar proteins: O97484, P02283, P02284, P02285, P02286, P02287, P02288, P02289, P04255, P04913, P08993, P08994, P0C1H4, P16888, P16889, P16890, P17271, P21897, P27795, P33778, P35067, P35068, P35069, P48557, P57053, P59781, P59782, P70696, P82887, P83863, Q00729, Q27442, Q27876, Q27894, Q41575, Q64524, Q6PC60, Q76FD7, Q76FE5, Q76FE9
Diamond homologs: A0A2R8Y619, A2WKT1, A2WKT4, A2WWU2, A2XF66, A2YWI3, A3AGM4, O22582, O60814, O65819, P02281, P02283, P02284, P02285, P02286, P02287, P02288, P02289, P02290, P04255, P06145, P06899, P06900, P07794, P07795, P0C1H3, P0C1H4, P0C1H5, P10853, P10854, P14001, P16888, P16889, P16890, P17271, P19374, P21897, P23527, P27326, P27807
SIGNOR signaling
2 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| SLBP | “up-regulates quantity by expression” | H2BC1 | “translation regulation” |
| “MSL acetyltransferase” | “down-regulates activity” | H2BC1 | monoubiquitination |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 37 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| B-WICH complex positively regulates rRNA expression | 5 | 21.7× | 6e-04 |
| Regulation of PD-L1(CD274) transcription | 5 | 19.4× | 6e-04 |
| NoRC negatively regulates rRNA expression | 5 | 18.7× | 6e-04 |
| Senescence-Associated Secretory Phenotype (SASP) | 5 | 17.7× | 6e-04 |
| Oxidative Stress Induced Senescence | 5 | 16.2× | 7e-04 |
| HCMV Early Events | 5 | 14.5× | 8e-04 |
| HATs acetylate histones | 5 | 14.2× | 8e-04 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
37 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 36 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
122 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 6:25726987:G:GT | donor_gain | 0.8800 |
| 6:25727018:A:T | donor_gain | 0.8700 |
| 6:25727007:GACCC:G | donor_gain | 0.8300 |
| 6:25727087:C:G | donor_gain | 0.8300 |
| 6:25727012:G:GG | donor_gain | 0.8200 |
| 6:25727017:G:GT | donor_gain | 0.8000 |
| 6:25726951:GGCTT:G | donor_gain | 0.7900 |
| 6:25727022:T:G | donor_gain | 0.7700 |
| 6:25726988:A:T | donor_gain | 0.7600 |
| 6:25727009:CCC:C | donor_gain | 0.7600 |
| 6:25727270:C:CG | donor_gain | 0.7200 |
| 6:25727086:GCTA:G | donor_gain | 0.6700 |
| 6:25727010:CC:C | donor_gain | 0.6600 |
| 6:25727289:G:GG | donor_gain | 0.6600 |
| 6:25727089:A:G | donor_gain | 0.6300 |
| 6:25726952:GCTT:G | donor_gain | 0.6200 |
| 6:25727007:G:GT | donor_gain | 0.6000 |
| 6:25726987:G:T | donor_gain | 0.5700 |
| 6:25727096:T:TG | donor_gain | 0.5500 |
| 6:25727270:C:G | donor_gain | 0.5500 |
| 6:25726970:T:G | donor_gain | 0.5400 |
| 6:25726934:C:CG | donor_gain | 0.5300 |
| 6:25727008:ACCCG:A | donor_loss | 0.5300 |
| 6:25727011:CG:C | donor_loss | 0.5300 |
| 6:25727012:GTAA:G | donor_loss | 0.5300 |
| 6:25727013:TAA:T | donor_loss | 0.5300 |
| 6:25727014:A:C | donor_loss | 0.5300 |
| 6:25727015:AGG:A | donor_loss | 0.5200 |
| 6:25727016:G:C | donor_loss | 0.5200 |
| 6:25727058:C:A | donor_gain | 0.5200 |
AlphaMissense
821 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 6:25727048:T:C | L47P | 0.999 |
| 6:25727143:G:C | A79P | 0.999 |
| 6:25727203:G:C | A99P | 0.999 |
| 6:25727204:C:A | A99E | 0.999 |
| 6:25727213:T:C | L102S | 0.999 |
| 6:25727239:C:G | H111D | 0.999 |
| 6:25727241:T:A | H111Q | 0.999 |
| 6:25727241:T:G | H111Q | 0.999 |
| 6:25727243:C:A | A112D | 0.999 |
| 6:25727254:G:C | G116R | 0.999 |
| 6:25727255:G:A | G116D | 0.999 |
| 6:25727263:G:C | A119P | 0.999 |
| 6:25727054:A:C | Q49P | 0.998 |
| 6:25727129:G:C | R74P | 0.998 |
| 6:25727153:T:C | L82S | 0.998 |
| 6:25727209:C:A | R101S | 0.998 |
| 6:25727210:G:C | R101P | 0.998 |
| 6:25727225:G:A | G106E | 0.998 |
| 6:25727231:T:A | L108Q | 0.998 |
| 6:25727231:T:C | L108P | 0.998 |
| 6:25727239:C:A | H111N | 0.998 |
| 6:25727240:A:C | H111P | 0.998 |
| 6:25727242:G:C | A112P | 0.998 |
| 6:25727254:G:T | G116C | 0.998 |
| 6:25727262:G:C | K118N | 0.998 |
| 6:25727262:G:T | K118N | 0.998 |
| 6:25727264:C:A | A119D | 0.998 |
| 6:25727267:T:A | V120D | 0.998 |
| 6:25727104:T:C | S66P | 0.997 |
| 6:25727144:C:A | A79E | 0.997 |
dbSNP variants (sampled 300 via entrez): RS1000483009 (6:25726835 A>C,G), RS1001893748 (6:25725930 G>A,C), RS1002155579 (6:25727382 A>C,G,T), RS1002647352 (6:25725867 C>T), RS1002664843 (6:25726026 G>A,C), RS1005764806 (6:25726955 T>A,C), RS1006907826 (6:25727473 G>A,C), RS1007182920 (6:25727667 G>A), RS1007632076 (6:25726429 A>G), RS1008162172 (6:25725205 A>G), RS1008738577 (6:25727549 A>C,T), RS1009145881 (6:25725966 T>A,G), RS1009661299 (6:25725103 G>A), RS1009935320 (6:25727691 A>G), RS1010526241 (6:25727016 G>A)
Disease associations
OMIM: gene MIM:609904 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004521_169 | Autism spectrum disorder or schizophrenia | 4.000000e-14 |
| GCST004521_69 | Autism spectrum disorder or schizophrenia | 8.000000e-24 |
| GCST004521_83 | Autism spectrum disorder or schizophrenia | 1.000000e-13 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL5724670 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
8 total (human), top 8 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, decreases expression | 2 |
| sodium arsenite | increases expression | 1 |
| epigallocatechin gallate | increases expression | 1 |
| Arsenic | affects methylation | 1 |
| Methylcholanthrene | affects binding, increases reaction | 1 |
| Valproic Acid | increases methylation | 1 |
| Copper Sulfate | affects expression | 1 |
| Nanotubes, Carbon | affects expression | 1 |
ChEMBL screening assays
6 unique, capped per target: 6 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL5697172 | Binding | Inhibition of HIST1H2BA (unknown origin) assessed as fold change at 10 uM incubated for 1 hr by colloidal coomassie staining based LC-MS/MS analysis | Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia. — Nature |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.